Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Explore which risk parity funds are retirement friendly and fit conservative to balanced retirement goals. A quick guide to evaluating suitability.
27,924 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
The OCC has approved Circle National Trust to operate as a national fiduciary bank focused on custody services, not r...
European markets tumbled on Monday as new Middle East tensions joined the AI scare trade, pushing oil higher and risk...
SPY trades near $668 amid rising oil to $100 and a higher VIX, yet retail traders on social forums stay bullish. The ...
After years of outsized gains, the magnificent seven faces a pullback. This guide explains how to evaluate the dip, p...
SoundHound AI has delivered notable revenue gains, even as its stock retreated. This article breaks down what's drivi...
Lululemon posted a mixed quarter: international sales led growth while the core US market softened. This analysis dig...
On tesla stock dropped tuesday, shares slid as investors weighed delivery expectations and a cautious analyst note. T...
Wall Street chatter about a SpaceX and Tesla merger has sparked a wave of questions. This article unpacks what the ph...
Glamsterdam targets a mid-2026 mainnet upgrade that aims to ease congestion and boost Ethereum’s throughput. Analysts...
As NetApp gears up for 2026 earnings, investors should focus on cloud services growth, margins, and free cash flow. T...
BingEx FLX is navigating a pivotal year. This article breaks down the Q4 2025 earnings, explains the key metrics, and...